Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Amati investors -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (28877)	11/19/1997 12:12:00 PM
From: Chemsync	Read Replies (1) \| Respond to of 31386

[Texas Instruments Home Page] ti.com <<TI will, subject to satisfaction of certain conditions, commence the all-cash tender offer on November 25, 1997, and the tender offer is scheduled to expire at midnight EST, December 23, 1997, unless extended. TI intends to acquire the Amati common stock through a wholly-owned subsidiary of TI. Any shares not purchased in the tender offer will be acquired for the tender offer price in cash in a second-step merger.>> FWIW sg

To: B.REVERE who wrote (28877)	11/19/1997 12:13:00 PM
From: Joe Griffin	Read Replies (1) \| Respond to of 31386

Bruce, Do you see the market buying Amati out at $30? Or, will the TI offer stand at $20? This gets complicated because of the Westell strategic relationship with TI. Does Westell get any assurance that TI will "protect" Westell's interest by uping the ante? As a Westell shareholder I am concerned that this could happen... Westell gets $14.7 M and does NOT end up with the strategic relationship it so desperately sought!

To: B.REVERE who wrote (28877)	11/19/1997 12:17:00 PM
From: Michael F. Donadio	Read Replies (1) \| Respond to of 31386

Bruce, your point is well taken. Amati is worth at least $30. I have been in other situations like this before. I owned genetic therapy which was bought in cash by the then Sandoz Pharmaceutical. They paid DOUBLE the current asking price for genetic therapy, which had never seen that price in its existence, and though it had great potential it was not as concrete as Amati's potential is. Amati HAS been to 36, has spent a good deal of time over 20, and had been hovering close to 20 prior to the market collapse. With ADSL deployment so imminent, double from $15 to $30 is not unreasonable. I'm waiting to hear a better offer. Wouldn't the Amati patents be great for Motorola or Lucent, or Alcatel for that matter? What is going on with Motorola and their chip? I am sure that is part of the story for this fire sale. I still say no to $20 cash. How about $30 and some options to buy Westell or TI at some reasonable price in the future? Michael

To: B.REVERE who wrote (28877)	11/19/1997 12:35:00 PM
From: Richard D	Respond to of 31386

<<the market has deemed that $30 is fair value for AMATI.>> Yes, I took Robert Cordiano's advice and bought 200 April 20's for 3/16, as relatively cheap speculation or hedge if I decide to unload my other in the money Amati. There has been ~2500 contracts traded on the April 20 Calls. I am not advising this for anyone else, since in all probability they will expire worthless. I simply like the possible upside. Regards, Richard

To: B.REVERE who wrote (28877)	11/19/1997 1:09:00 PM
From: Meghan Richards	Respond to of 31386

You've got to be dreaming. TI has a market cap of roughly $18B. This purchase is hardly signifcant enough to have more than a ripple impact. What's more important is the potential market TI may be moving into. Looking at this from a business prospective, all TI had to do was better the offer that Amati had already agreed to. And they did ... they re-iterated the price IN CASH, plus offered them a more secure future. Amati pretty much shot down hopes of a $30/share price when they agreed to the WSTL acquisition. The offer was sort of weak (offering limited futuristic potential and not cash). In short ... be happy with today's nice increase. Your investment in Amati has now maxed out. Use your profits to capitalize in similar investments.